Trial Profile
Cohort Study Of Venous Thromboembolism And Other Clinical Endpoints Among Osteoporotic Women Prescribed Bazedoxifene, Bisphosphonates Or Raloxifene In Europe.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2020
Price :
$35
*
At a glance
- Drugs Bazedoxifene (Primary) ; Bisphosphonates; Raloxifene
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions
- Sponsors Pfizer
- 03 Jun 2019 Status changed from active, no longer recruiting to completed.
- 14 Mar 2018 Planned End Date changed from 30 Apr 2019 to 1 Apr 2019.
- 14 Mar 2018 Planned primary completion date changed from 30 Apr 2019 to 1 Apr 2019.